Rimiterol hydrobromide is a direct-acting sympathomimetic agent that functions as a selective β2-adrenergic receptor agonist, primarily indicated for the management of bronchial asthma to relieve airway… Read more
Rimiterol hydrobromide is a direct-acting sympathomimetic agent that functions as a selective β2-adrenergic receptor agonist, primarily indicated for the management of bronchial asthma to relieve airway constriction. This category provides access to essential analytical materials, including reference standards of the active pharmaceutical ingredient, pharmacopeial and non-pharmacopeial impurities, and stable isotope labelled compounds such as Rimiterol-d4 hydrobromide. These compounds are vital for pharmaceutical laboratories conducting rigorous impurity profiling, method validation, and quality control testing. By serving as high-precision internal standards in chromatographic and mass spectrometric analysis, these reference materials enable researchers to ensure accurate quantification, confirm structural integrity, and maintain compliance with stringent regulatory standards throughout pharmaceutical development and manufacturing processes.